further & higher education
health & social care

Improving NHS Outcomes Through Research, Funding and Innovation

further & higher education

health & social care

08:45 - 16:10

Wednesday 27 February 2019

Central London

This Forum will provide delegates with the opportunity to survey the current policy landscape and funding opportunities for research and innovation in healthcare whilst also hearing about the transformative impact that outstanding research and innovation has had on the health sector. Attendees will explore insights from NHS Trusts, think tanks, medical research institutes and HE institutions on how to produce outstanding, innovative research that has a wide-ranging impact on health outcomes across the NHS. Moreover, best practice case studies will examine how cross-sector collaboration, patient involvement in research, emerging technologies and data can enhance healthcare practices and improve outcomes.


This even is specifically designed for the Higher Education, Healthcare and Private sectors. Typical job titles will include:

  • Heads of Research Development
  • Medical Directors
  • Medical Researchers
  • Science Advisers
  • Senior Health Researchers
  • Deputy and Pro-Vice Chancellors
  • NHS Directors of Research and Development
  • Senior Professors
  • Deans of Research and Enterprise
  • Innovation Managers
  • Heads of Engagement

This event will also be open to the Voluntary and Private sectors to encourage networking, discussion and debate.

Key Speakers Confirmed:
  • Chris Green MP, Chair, All-Party Parliamentary Group on Medical Research
  • Dr Kath Mackay, Interim Director – Ageing Society, Health & Nutrition, Innovate UK
  • Dr Robin Buckle, Chief Science Officer, Medical Research Council
  • Dr Usha Boolaky, Senior Research Manager, Health Foundation


View the agenda and additional speakers


There are numerous worrying health trends occurring across the UK including the fact that 850,000 people in the UK have dementia, with numbers expected to rise indefinitely. Whilst it has also been projected that half of the UK population will be obese by 2030 if current trends continue. The NHS remains severely strained in the face of an ageing population, financial difficulties and ongoing public health issues.

Research and innovation in healthcare will be at the forefront of combating these issues. The government’s commitment to spend 2.4% of GDP on research and development by 2027 offers a prime opportunity to advance health outcomes across a wide range of areas through targeted research and innovation. In July 2018, Jeremy Hunt announced £215 million in funding for research into emerging health issues and the pressures facing the NHS. Furthermore, Innovate UK announced up to £6 million will be available in grant funding for precision medicine projects that improve the diagnosis, monitoring and treatment of disease. A Biomedical Catalyst fund of £10 million has also been formed between Innovate UK and the Medical Research Council to support innovation in the life sciences sector, while Health Data Research UK was formed in 2017 to address challenging healthcare issues through utilising data science.

For health research and innovation to be truly effective, institutions from government, healthcare, the voluntary sector, higher education and industry must collaborate, share ideas and collectively advance knowledge around medicine, nutrition, healthy living, and organisational effectiveness. More attention must also be paid to the social, environmental, digital and behavioural aspects of health if the highest standards of healthcare across the UK are to be achieved.


Registration, Refreshments and Networking


Chair's Welcome Address

Bob Erens, Deputy Director, Policy Innovation Research Unit (invited)


Morning Keynote: Ensuring the Success of the UK's Medical Research Sector Post-Brexit

  • Outlining the APPG’s role in providing a forum for parliamentarians with an interest in medical research to communicate, collaborate and network with medical research professionals
  • Evaluating the impact of Brexit on medical research capacity, and exploring opportunities to enhance the UK’s world-leading research status
  • Ensuring the continuation of international collaboration and mobility between medical researchers and health experts in the UK and wider global community post-Brexit
  • Understanding the crucial role played by patient data in medical research by enabling practitioners to deliver more effective treatments, interventions and diagnoses
  • Analysing medical research funding implications in a post-Brexit environment

Chris Green MP, Chair, All-Party Parliamentary Group on Medical Research (CONFIRMED)


Special Keynote: Supporting Innovative Research to Enhance The Health of the UK Population

  • Outlining the competitive funding opportunities available as part of the £300 million landmark ageing society Grand Challenge
  • Delivering the leading-edge healthcare challenge as part of the Industrial Strategy Challenge Fund, investing £181 million to accelerate access to new medicines and drugs and improve healthcare
  • Awarding £21 million to companies, universities and NHS hospitals to establish advanced therapy treatment centres designed to develop new medicines for treating blood cancer
  • Funding multidisciplinary teams of clinicians, academics, product-developers and logistics companies to create bespoke systems capable of operating across the entire NHS
  • Emphasising the importance of supporting innovation in health and nutrition, alongside clinical and biomedical research, to improve public health outcomes

Dr Kath Mackay, Interim Director – Ageing Society, Health & Nutrition, Innovate UK (CONFIRMED)


Sponsored Session


Questions and Answers Session


Refreshments and Networking


Case Study: Forging Effective Partnerships to Deliver Outstanding, High-Impact Health Research

  • Championing the importance of cross-sectoral expert partnerships to maximise the effectiveness, innovativeness and impact of health research
  • Leading the fight against antibiotic-resistant bacteria through CARB-X, a collaborative accelerator project
  • Bringing together industry, government, universities, charities and research institutes across seven countries
  • Funding interdisciplinary research collaborations through the UK Prevention Research Partnership scheme, in order to effectively tackle primary prevention of non-communicable diseases in the UK
  • Committing £6 million in funding for partnerships with the universities of Bristol, Cambridge, Edinburgh, Manchester, Imperial College and Oxford to translate health research discoveries into real world impact

Chonnettia Jones, Director of Insight and Analysis, Wellcome Trust (invited)


Case Study: Enhancing Research Impact in NHS Trusts through Collaboration and Patient Involvement

  • Increasing the number of patient participants in clinical research studies by 191% over the last year, the largest percentage increase of any acute trust across the UK
  • Outlining the integral role of research in improving patient care and ensuring patients have access to cutting-edge treatments and medicines
  • Working with the life science industry to finance research studies and produce new, innovative treatments and cures to enhance health outcomes
  • Explaining how patient involvement contributes to the impact and effectiveness of clinical research
  • Collaborating with healthcare workers, clinicians and academics to boost the quality and quantity of research efforts within the trust

Dr Nnenna Osuji, Medical Director, Croydon Health Services NHS Trust (invited)


Case Study: Translating Health Research into Practical Resources for Practitioners

  • Leading the Health Protection Research Unit in Healthcare Associated Infections (HCAI) and Antimicrobial Resistance (AMR), funded by NIHR and in collaboration with Public Health England
  • Undertaking research across 12 public health priority areas to inform public health policy; developing tools, guidelines and resources for use by healthcare practitioners
  • Showcasing the Imperial Antibiotic Prescribing Policy (IAPP) mobile application, which provides clinical decision support at the point of care to improve antimicrobial stewardship
  • Outlining the research value of partnering with the Wellcome Trust Sanger Institute, the Cambridge Veterinary School and the North West London Academic Health Science Network

Alison Holmes, Professor of Infectious Diseases, Imperial College London, Fellow, Academy of Medical Sciences, and Senior Investigator, NIHR (invited)


Questions and Answers Session


Lunch and Networking


Afternoon Keynote: Funding the Vanguard of Medical Researchers to Enhance Healthcare Outcomes

  • Shaping the UK biomedical research landscape through strategic funding of cutting-edge research projects across a variety of fields, including infections and immunity, cellular medicine, neurosciences and mental health
  • Supporting creative and innovative clinical scientists to balance their research endeavours with their professional workloads and responsibilities
  • Detailing how £600m in annual funding is allocated; outlining researcher-led and MRC strategic funding opportunities
  • Working with Alzheimer’s Society and Alzheimer’s Research UK to invest £250m in a new UK Dementia Research Institute, in accordance with the Prime Minister’s 2020 Challenge on Dementia
  • Demonstrating high-impact health outcomes through MRC-funded research, such as implementing adaptive clinical trials to transform the efficiency of drug development and expedite patient access to effective treatments

Dr Robin Buckle, Chief Science Officer, Medical Research Council (CONFIRMED)


Panel Session: Looking Towards the Future of Health Research and Innovation

  • Exploring what the future of health research and innovation will look like, highlighting sector challenges, and discussing strategies to overcome these obstacles in the short and long term
  • Developing appropriate and accurate metrics to robustly measure improvements in healthcare as we move forward
  • Assessing the growing role of charities in funding and executing research to enhance public health and wellbeing
  • Identifying health priorities for research efforts, and analysing how best to deliver impactful outcomes

Delegates can submit questions/discussion topics on the day using the Sli.do application 

Iain Foulkes PhD, Executive Director – Research & Innovation, Cancer Research UK (invited)

Professor Gillian Leng, Deputy Chief Executive and Director of Health and Social Care, National Institute for Health and Social Care Excellence (NICE) (invited)

Dr Liz Philpots, Head of Research & Impact, Association of Medical Research Charities (AMRC) (invited)


Refreshments and Networking


Case Study: Bursting the Biomedical Bubble – Rebalancing Research Funding to Improve Public Health

  • Rebalancing investment in research and innovation away from the biomedical and pharmaceutical industries
  • Placing a greater emphasis on the social, environmental, digital and behavioural determinants of health to achieve a more holistic understanding of health and wellbeing
  • Bringing a more strategic and health-oriented approach to funding and prioritisation of research and development
  • Understanding that the increasing strain and pressure on health and social care services in the UK requires a reconsideration of research priorities
  • Engaging all aspects of the research and innovation community to ensure the transition towards a greater diversity of priorities, people, politics and places when it comes to enhancing health outcomes

Richard Jones, Professor of Physics, and James Wilsdon, Professor of Research Policy and Director of Research and Innovation – Faculty of Social Sciences, University of Sheffield (invited)


Closing Keynote: Making Health Policymaking More Effective Through Comprehensive and Evidence-Based Research

  • Evaluating the success of the Health Foundation’s 2015-2018 strategy with regards to assessing the impact of their research efforts on public health policy
  • Commissioning research to help to build knowledge about the impact of policy reforms on the quality of health care across the UK
  • Funding external research into health care topics such as system efficiency, value for money, trends in quality, financing of NHS-funded care and key health care reforms
  • Monitoring healthcare quality through QualityWatch, a joint programme with the Nuffield Trust that tracks broad measures of the quality of health and social care

Dr Usha Boolaky, Senior Research Manager, Health Foundation (CONFIRMED)


Questions and Answers Session


Chair's Summary and Close

*Programme subject to change

You May Also Like